CClinicalTrials.gg
TerminatedNCT00674037COFRASAancUpdated Nov 2, 2014

Efficacy of Monetary Incentives for Primary Care Physicians on Patients

An interventional study of monetary incentive in Recruitment, sponsored by Assistance Publique - Hôpitaux de Paris. Terminated at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-11-02.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable and Interventional

Why this study was terminated
default inclusion
Phase
Not applicable
Study type
Interventional
Enrollment
170
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients' recruitment is difficult in clinical trial. Financial incentives are frequently proposed to clinicians in private funded trials. However, the effect of these financial incentives has never been evaluated.

The purpose of this study is to evaluate the effect of financial incentive on the rate of recruitment of patients in a cohort study.

Read the detailed description

Context: Patients' recruitment is difficult in clinical trials. Financial incentives are frequently proposed to clinicians in private funded trials. However, the effect of these financial incentives has never been evaluated.

Objective: to evaluate the effect of financial incentive on the rate of recruitment of patients in a cohort study.

Design: randomized controlled trial Setting: primary care Participants: physicians (GP and cardiologists) participating in the recruitment of patients in a cohort study (the COFRASA study). The COFRASA cohort study is including aortic stenosis aging patient.

Intervention:75 euros for each patient included Main outcome: percentage of physician including at least one patient at 3 months Secondary outcome: mean number of patients included at 6 months. Sample size 270 physicians

02

Conditions studied

  • Recruitment

Keywords

  • recruitment
  • physicians participating in the recruitment of patients
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Physicians participating in the COFRASA cohort study
  • informed consent

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
170 participants (actual)

Study arms

  • Experimental
    inclusion with financial motivation

    75 euros for each patient included

    Other: monetary incentive

  • No intervention
    no incentive

    no incentive

Interventions

  • Othermonetary incentive

    75 euros for each patient included

06

What researchers measure

Primary outcomes

  1. number of patient included

    Time frame: 3 months

Secondary outcomes

  1. number of patient included

    Time frame: 6 month

07

Study locations

1 site
  • Groupe hospitalier Bichat-Claude Bernard
    Paris, 75018, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 2, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00674037
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
May 7, 2008
Start date
Sep 2006
Primary completion
Sep 2011
Completion
Sep 2011
Last update
Nov 2, 2014

Study contacts

Isabelle BOUTRON, MD
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion